2 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow iloperidone: new trials by email Literature Review of iloperidone trials Research Report on iloperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension iloperidone, Placebo - Hypertension, Uncontrolled Hypertension | Phase 2 | Recruiting | Vanda Pharmaceuticals | 240 | 2025-09-15 | 2026-02-27 |
| A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis Iloperidone - Parkinson Disease Psychosis | Phase 2 | Withdrawn | Vanda Pharmaceuticals | 2022-06-01 | 2024-03-21 | |
| Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD) Iloperidone, Placebo - Post Traumatic Stress Disorder | Phase 2 | Terminated | University of Colorado, Denver | 1 | 2013-07-01 | 2020-02-11 |
| Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia iloperidone, Risperidone - Schizophrenia, Iloperidone | Phase 2 | Completed | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 260 | 2012-06-01 | 2013-11-19 |
| Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients Iloperidone crystalline formulation, Iloperidone microparticle formulation, Oral iloperidone - Schizophrenia | Phase 1 / Phase 2 | Completed | Novartis Pharmaceuticals | 81 | 2011-04-01 | 2014-01-22 |
Schizophrenia (2) · Hypertension (1) · Stress Disorders, Post-Traumatic (1)
Vanda Pharmaceuticals (2) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Novartis Pharmaceuticals (1) · University of Colorado, Denver (1)
United States (4) · China (1)